Suchergebnisse - "Rudenko, Larisa"

PubPharm (8)

1

A promising inactivated whole-virion SARS-CoV-2 vaccine

enthalten in: The Lancet. Infectious diseases | 2021

von Isakova-Sivak, I. | Rudenko, L.

2

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine

enthalten in: Expert review of vaccines | 2018

von Korenkov, D. | Isakova-Sivak, I. | Rudenko, L.

3

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses : Process challenges and success stories

enthalten in: Vaccine | 2016

von Rudenko, L. | Yeolekar, L. | Kiseleva, I. | +1

4

Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses : Geneva, Switzerland, 5-7 May 2014

enthalten in: Vaccine | 2015

von Cox, N. | Hickling, J. | Jones, R. | +8

5

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine

enthalten in: Vaccine | 2015

von Carter, D. | Bloom, C. | Kirchenbaum, G. | +4

ExpressionOfConcernIn: Vaccine. 2024 Mar 7;42(7):1851. - PMID 38485299

6

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine

enthalten in: Human vaccines & immunotherapeutics | 2015

von Rudenko, L. | Naykhin, A. | Donina, S. | +9

7

Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine)

enthalten in: Influenza and other respiratory viruses | 2012

von Gambaryan, A. | Lomakina, N. | Boravleva, E. | +5

8

Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets

enthalten in: The Journal of infectious diseases | 2011

von Gustin, K. | Maines, T. | Belser, J. | +14

1
[1]